Rubius rises after banking $241.1M in upsized IPO

Cellular therapy company Rubius Therapeutics Inc. (NASDAQ:RUBY) climbed $1.25 to $24.25 in its first day of trading Wednesday

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE